Global Nuclear Medicine Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 219
Status: Published
Report Code: ARI101032
Nuclear medicine is a specialized area of radiology that uses very small amounts of radioactive materials, or radiopharmaceuticals, to examine organ function and structure. Nuclear medicine imaging is a combination of many different disciplines.
However, X-rays pass through soft tissue, such as intestines, muscles, and blood vessels, these tissues are difficult to visualize on a standard X-ray, unless a distinction agent is used. This allows the tissue to be seen more clearly. Nuclear imaging enables visualization of organ and tissue structure as well as function. The extent to which a radiopharmaceutical is absorbed, by a particular organ or tissue may indicate the level of function of the organ or tissue being studied. Thus, diagnostic X-rays are used primarily to study anatomy. Nuclear imaging is used to study organ and tissue function.
A small amount of a radioactive substance is used during the procedure to assist in the exam. The radioactive substance, called a radionuclide or radiopharmaceutical, is absorbed by body tissue. Several different types of radionuclides are available. These include forms of the elements technetium, thallium, gallium, iodine, and xenon. The type of radionuclide used will depend on the type of study and the body part being studied.
Because of Nuclear Medicines, the healthcare provider can assess and diagnose various conditions, such as tumors, infections, hematomas, organ enlargement, or cysts. A nuclear scan may also be used to assess organ function and blood circulation.
Currently, the success of radio ligand therapy and theranostics again tremendously affects the required knowledge, expertise, and therefore training of nuclear medicine specialists. However, this is just the beginning indeed, digital PET, new PET tracers, a wave of new theranostic compounds, and the rise of artificial intelligence and machine learning will change the daily practice of nuclear medicine even more.
Some of the key prominent players in Nuclear Medicine Market are Cardinal Health, GE Healthcare , Curium , Lantheus Medical Imaging , Bayer AG , Bracco Imaging , Eczacýbaþý-Monrol Nuclear Products , Nordion , Advanced Accelerator Applications , and NTP Radioisotopes. In 2021, Bracco entered into a partnership with CardioNavix which will help improve patient access to cardiac PET imaging.
Table of Contents
Chapter 1 Executive Summary 19
1.1 Global Nuclear Medicine Market: Executive Summary 19
1.1.1 Global Nuclear Medicine Market Volume, 2015-2028(TBq) 19
1.1.2 Global Nuclear Medicine Market Revenue, 2015-2028(USD Million) 20
Chapter 2 Research Methodology 22
2.1 Methodology/Research Approach 22
2.1.1 Research Programs/Design 22
2.1.2 Market Size Estimation 23
2.2 Data Source 23
2.2.1 Secondary Sources 23
2.2.1.1 Preliminary data mining 24
2.2.2 Primary Sources 24
2.2.2.1 Data Collection Matrix 26
2.2.3 Statistical model 26
2.2.4 Data Triangulation 27
2.2.5 Report Objectives 27
Chapter 3 Market Outlook 28
3.1 Introduction 28
3.2 Key Trends 28
3.2.1 Diagnostics Segment Growing Significantly in Near Future 28
3.3 Market Drivers 29
3.3.1 Increasing incidence and prevalence of target conditions 29
3.3.2 Growing demand for accurate diagnostic methods 29
3.4 Market Restraints 29
3.4.1 Short half-life of radiopharmaceuticals 29
3.5 Market Opportunities 30
3.5.1 Use of radiopharmaceuticals in neurological applications 30
3.6 Market Challenges 30
3.6.1 High costs associated with diagnostics & therapeutic procedures 30
3.7 Impact Analysis of Driver, Restraint, Opportunity and Challenge 31
3.8 Porter’s Five Forces Analysis 32
3.8.1 Bargaining Power of Suppliers: Moderate 32
3.8.2 Bargaining Power of Buyers: Moderate to High 33
3.8.3 Threat of New Entrants: Moderate 34
3.8.4 Threat of Substitutes: Moderate 35
3.8.5 Competitive Rivalry: Moderate 36
3.9 Value Chain Analysis 37
Chapter 4 Impact of COVID-19 on Nuclear Medicine Market 38
Chapter 5 Global Nuclear Medicine Market Overview, By Product Type 2015 - 2028 39
5.1 Global Nuclear Medicine Market Share, By Product Type, 2021 and 2028 (%) 39
5.2 Global Nuclear Medicine Market Volume, By Product Type, 2015 - 2028 (USD Million) 40
5.3 Global Nuclear Medicine Market Revenue, By Product Type, 2015 - 2028 (USD Million) 41
5.3.1 Diagnostics 42
5.3.1.1 Introduction 42
5.3.1.2 Global Nuclear Medicine Market Volume, by Diagnostics, By Product Type,2015-2028 (TBq) 43
5.3.1.3 Global Nuclear Medicine Market Revenue, by Diagnostics, By Product Type,2015-2028 (USD Million) 43
5.3.1.4 Global Nuclear Medicine Market Volume, by Diagnostics, By Product Type, by Region 2015-2028(TBq) 44
5.3.1.5 Global Nuclear Medicine Market Revenue, by Diagnostics, By Product Type, by Region 2015-2028(USD Million) 45
5.3.1.6 Global Nuclear Medicine Market Volume, by Diagnostics, By SPECT, 2015-2028(TBq) 46
5.3.1.7 Global Nuclear Medicine Market Volume, by Diagnostics, By PET, 2015-2028(TBq) 47
5.3.1.8 Global Nuclear Medicine Market Revenue, by Diagnostics, By SPECT, 2015-2028(USD Million) 48
5.3.1.9 Global Nuclear Medicine Market Revenue, by Diagnostics, By PET, 2015-2028(USD Million) 49
5.3.2 Therapeutics 50
5.3.2.1 Introduction 50
5.3.2.2 Global Nuclear Medicine Market Volume, by Therapeutics, By Product Type, 2015-2028 (TBq) 51
5.3.2.3 Global Nuclear Medicine Market Revenue, by Therapeutics, By Product Type, 2015-2028 (USD Million) 51
5.3.3 Global Nuclear Medicine Market Volume, By Therapeutics, 2015 - 2028 (TBq) 52
5.3.4 Global Nuclear Medicine Market Revenue, By Therapeutics, 2015 - 2028 (USD Million) 53
5.3.4.1 Global Nuclear Medicine Market Volume, by Therapeutics, By Alpha Emitters, 2015-2028(TBq) 54
5.3.4.2 Global Nuclear Medicine Market Volume, by Therapeutics, By Beta Emitters, 2015-2028(TBq) 55
5.3.4.3 Global Nuclear Medicine Market Revenue, by Therapeutics, By Alpha Emitters, 2015-2028(USD Million) 56
5.3.4.4 Global Nuclear Medicine Market Revenue, by Therapeutics, By Beta Emitters, 2015-2028(USD Million) 57
Chapter 6 Global Nuclear Medicine Market Overview, By Application, 2015 - 2028 58
6.1 Global Nuclear Medicine Market Share, By Application, 2021 and 2028 (%) 58
6.2 Global Nuclear Medicine Market Volume, By Application, 2015 - 2028 (TBq) 59
6.3 Global Nuclear Medicine Market Revenue, By Application, 2015 - 2028 (USD Million) 60
6.3.1 Cardiology 61
6.3.1.1 Introduction 61
6.3.1.2 Global Nuclear Medicine Market Volume, by Cardiology, By Application,2015-2028 (TBq) 62
6.3.1.3 Global Nuclear Medicine Market Revenue, by Cardiology, By Application,2015-2028 (USD Million) 62
6.3.1.4 Global Nuclear Medicine Market Volume, by Cardiology, By Application, by Region, 2015-2028(TBq) 63
6.3.1.5 Global Nuclear Medicine Market Revenue, by Cardiology, By Application, by Region, 2015-2028(USD Million) 64
6.3.2 Neurology 65
6.3.2.1 Introduction 65
6.3.2.2 Global Nuclear Medicine Market Volume, by Neurology, By Application,2015-2028 (TBq) 66
6.3.2.3 Global Nuclear Medicine Market Revenue, by Neurology, By Application,2015-2028 (USD Million) 66
6.3.2.4 Global Nuclear Medicine Market Volume, by Neurology, By Application, by Region, 2015-2028(TBq) 67
6.3.2.5 Global Nuclear Medicine Market Revenue, by Neurology, By Application, by Region, 2015-2028(USD Million) 68
6.3.3 Oncology 69
6.3.3.1 Introduction 69
6.3.3.2 Global Nuclear Medicine Market Volume, by Oncology, By Application,2015-2028 (TBq) 70
6.3.3.3 Global Nuclear Medicine Market Revenue, by Oncology, By Application,2015-2028 (USD Million) 70
6.3.3.4 Global Nuclear Medicine Market Volume, by Oncology, By Application, by Region 2015-2028(TBq) 71
6.3.3.5 Global Nuclear Medicine Market Revenue, by Oncology, By Application, by Region 2015-2028(USD Million) 72
6.3.4 Thyroid 73
6.3.4.1 Introduction 73
6.3.4.2 Global Nuclear Medicine Market Volume, by Thyroid, By Application,2015-2028 (TBq) 74
6.3.4.3 Global Nuclear Medicine Market Revenue, by Thyroid, By Application,2015-2028 (USD Million) 74
6.3.4.4 Global Nuclear Medicine Market Volume, by Thyroid, By Application, by Region 2015-2028(TBq) 75
6.3.4.5 Global Nuclear Medicine Market Revenue, by Thyroid, By Application, by Region 2015-2028(USD Million) 76
6.3.5 Other 77
6.3.5.1 Introduction 77
6.3.5.2 Global Nuclear Medicine Market Volume, by Other, By Application,2015-2028 (TBq) 78
6.3.5.3 Global Nuclear Medicine Market Revenue, by Other, By Application,2015-2028 (USD Million) 78
6.3.5.4 Global Nuclear Medicine Market Volume, by Other, By Application, by Region 2015-2028(TBq) 79
6.3.5.5 Global Nuclear Medicine Market Revenue, by Other, By Application, by Region 2015-2028(USD Million) 80
Chapter 7 Global Nuclear Medicine Market Overview, By Geography, 2015 - 2028 81
7.1 Global Nuclear Medicine Market Share, By Geographic Regions, 2021 & 2028 (%) 81
7.2 Global Nuclear Medicine Market Volume, By Geographic Regions, 2015 - 2028 (TBq) 82
7.3 Global Nuclear Medicine Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million) 83
Chapter 8 North America Nuclear Medicine Market Overview, By Countries 84
8.1 North America Nuclear Medicine Market Overview, 2015 - 2028 84
8.1.1 Introduction 84
8.2 North America Nuclear Medicine Market Volume, 2015 & 2028 (TBq) 85
8.3 North America Nuclear Medicine Market Revenue, 2015 & 2028 85
8.3.1 North America Nuclear Medicine Market Volume, By Product Type, 2015 - 2028 (TBq) 86
8.3.2 North America Nuclear Medicine Market Revenue, By Product Type, 2015 - 2028 (USD Million) 87
8.3.3 North America Nuclear Medicine Market Volume, By Application, 2015 - 2028 (TBq) 88
8.3.4 North America Nuclear Medicine Market Revenue, By Application, 2015 - 2028 (USD Million) 89
8.3.5 North America Nuclear Medicine Market Share, By Countries Analysis, 2015 - 2028 90
8.3.6 North America Nuclear Medicine Market Volume Overview, By Countries, 2015 - 2028(TBq) 91
8.3.7 North America Nuclear Medicine Market Revenue Overview, By Countries, 2015 - 2028(USD Million) 92
8.3.7.1.1 US Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 93
8.3.7.1.2 US Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 93
8.3.7.1.3 US Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 94
8.3.7.1.4 US Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 95
8.3.7.1.5 Canada Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 96
8.3.7.1.6 Canada Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 96
8.3.7.1.7 Canada Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 97
8.3.7.1.8 Canada Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 98
8.3.7.1.9 Mexico Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 99
8.3.7.1.10 Mexico Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 99
8.3.7.1.11 Mexico Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 100
8.3.7.1.12 Mexico Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 101
Chapter 9 Europe Nuclear Medicine Market Overview, By Countries 102
9.1 Europe Nuclear Medicine Market Overview, 2015 - 2028 102
9.1.1 Introduction 102
9.2 Europe Nuclear Medicine Market Volume, 2015 & 2028 (TBq) 103
9.3 Europe Nuclear Medicine Market Revenue, 2015 & 2028 (USD Million) 103
9.3.1 Europe Nuclear Medicine Market Volume, By Product Type, 2015 - 2028 (TBq) 104
9.3.2 Europe Nuclear Medicine Market Revenue, By Product Type, 2015 - 2028 (USD Million) 105
9.3.3 Europe Nuclear Medicine Market Volume, By Application, 2015 - 2028 (TBq) 106
9.3.4 Europe Nuclear Medicine Market Revenue, By Application, 2015 - 2028 (USD Million) 107
9.3.5 Europe Nuclear Medicine Market Share, By Countries Analysis, 2021 & 2028 (%) 108
9.3.6 Europe Nuclear Medicine Market Volume Overview, By Countries, 2015 - 2028 (TBq) 109
9.3.7 Europe Nuclear Medicine Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 110
9.3.7.1.1 Germany Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 111
9.3.7.1.2 Germany Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 111
9.3.7.1.3 Germany Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 112
9.3.7.1.4 Germany Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 113
9.3.7.1.5 UK Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 114
9.3.7.1.6 UK Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 114
9.3.7.1.7 UK Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 115
9.3.7.1.8 UK Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 116
9.3.7.1.9 France Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 117
9.3.7.1.10 France Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 117
9.3.7.1.11 France Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 118
9.3.7.1.12 France Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 119
9.3.7.1.13 Italy Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 120
9.3.7.1.14 Italy Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 120
9.3.7.1.15 Italy Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 121
9.3.7.1.16 Italy Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 122
9.3.7.1.17 Spain Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 123
9.3.7.1.18 Spain Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 123
9.3.7.1.19 Spain Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 124
9.3.7.1.20 Spain Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 125
9.3.7.1.21 ROE Nuclear Medicine Market Volume Overview, By Product Type, 2015 - 2028 (TBq) 126
9.3.7.1.22 ROE Nuclear Medicine Market Revenue Overview, By Product Type, 2015 - 2028 (USD Million) 126
9.3.7.1.23 ROE Nuclear Medicine Market Volume Overview, By Application, 2015 - 2028 (TBq) 127
9.3.7.1.24 ROE Nuclear Medicine Market Revenue Overview, By Application, 2015 - 2028 (USD Million) 128
Chapter 10 Asia Pacific Nuclear Medicine Market Overview, By Countries 129
10.1 Asia Pacific Nuclear Medicine Market Overview, 2015 - 2028 (USD Million) 129
10.1.1 Introduction 129
10.2 Asia Pacific Nuclear Medicine Market Volume, 2015 – 2028 (TBq) 130
10.3 Asia Pacific Nuclear Medicine Market Revenue, 2015 - 2028 130
10.3.1 Asia Pacific Nuclear Medicine Market Volume, By Product Type, 2015 - 2028 (TBq) 131
10.3.2 Asia Pacific Nuclear Medicine Market Revenue, By Product Type, 2015 - 2028 (USD Million) 131
10.3.3 Asia Pacific Nuclear Medicine Market Volume, By Application, 2015 - 2028 (TBq) 132
10.3.4 Asia Pacific Nuclear Medicine Market Revenue, By Application, 2015 - 2028 (USD Million) 133
10.3.5 Asia Pacific Nuclear Medicine Market Share, By Countries Analysis, 2021 & 2028 (%) 134
10.3.6 Asia Pacific Nuclear Medicine Market Volume Overview, By Countries, 2015 - 2028 (TBq) 135
10.3.7 Asia Pacific Nuclear Medicine Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 136
10.3.7.1 China Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 137
10.3.7.2 China Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 137
10.3.7.3 China Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 138
10.3.7.4 China Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 139
10.3.7.5 India Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 140
10.3.7.6 India Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 140
10.3.7.7 India Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 141
10.3.7.8 India Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 142
10.3.7.9 Japan Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 143
10.3.7.10 Japan Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 143
10.3.7.11 Japan Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 144
10.3.7.12 Japan Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 145
10.3.7.13 South Korea Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 146
10.3.7.14 South Korea Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 146
10.3.7.15 South Korea Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 147
10.3.7.16 South Korea Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 148
10.3.7.17 ROA Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 149
10.3.7.18 ROA Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 149
10.3.7.19 ROA Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 150
10.3.7.20 ROA Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 151
Chapter 11 Middle East & Africa Nuclear Medicine Market Overview, By Countries 152
11.1 Middle East & Africa Nuclear Medicine Market Overview, 2015 - 2028 (USD Million) 152
11.1.1 Introduction 152
11.2 Middle East & Africa Nuclear Medicine Market Volume, 2015 – 2028 (TBq) 153
11.3 Middle East & Africa Nuclear Medicine Market Revenue, 2015 – 2028 (USD Million) 153
11.3.1 Middle East & Africa Nuclear Medicine Market Volume, By Product Type, 2015 - 2028 (TBq) 154
11.3.2 Middle East & Africa Nuclear Medicine Market Revenue, By Product Type, 2015 - 2028 (USD Million) 154
11.3.3 Middle East & Africa Nuclear Medicine Market Volume, By Application, 2015 - 2028 (TBq) 155
11.3.4 Middle East & Africa Nuclear Medicine Market Revenue, By Application, 2015 - 2028 (USD Million) 156
11.3.5 Middle East & Africa Nuclear Medicine Market Share, By Countries Analysis, 2021 & 2028 (%) 157
11.3.6 Middle East & Africa Nuclear Medicine Market Volume Overview, By Countries, 2015 - 2028 (TBq) 158
11.3.7 Middle East & Africa Nuclear Medicine Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 159
11.3.7.1 GCC Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 160
11.3.7.2 GCC Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 160
11.3.7.3 GCC Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 161
11.3.7.4 GCC Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 162
11.3.7.5 South Africa Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 163
11.3.7.6 South Africa Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 163
11.3.7.7 South Africa Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 164
11.3.7.8 South Africa Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 165
11.3.7.9 ROMEA Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 166
11.3.7.10 ROMEA Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 166
11.3.7.11 ROMEA Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 167
11.3.7.12 ROMEA Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 168
Chapter 12 South America Nuclear Medicine Market Overview, By Countries 169
12.1 South America Nuclear Medicine Market Overview, 2015 - 2028 (USD Million) 169
12.1.1 Introduction 169
12.2 South America Nuclear Medicine Market Volume, 2015 – 2028 (TBq) 170
12.3 South America Nuclear Medicine Market Revenue, 2015 – 2028 (USD Million) 170
12.3.1 South America Nuclear Medicine Market Volume, By Product Type, 2015 - 2028 (TBq) 171
12.3.2 South America Nuclear Medicine Market Revenue, By Product Type, 2015 - 2028 (USD Million) 171
12.3.3 South America Nuclear Medicine Market Volume, By Application, 2015 - 2028 (TBq) 172
12.3.4 South America Nuclear Medicine Market Revenue, By Application, 2015 - 2028 (USD Million) 173
12.3.5 South America Nuclear Medicine Market Share, By Countries Analysis, 2021 & 2028 174
12.3.6 South America Nuclear Medicine Market Volume Overview, By Countries, 2015 - 2028 (TBq) 175
12.3.7 South America Nuclear Medicine Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 176
12.3.7.1 Brazil Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 177
12.3.7.2 Brazil Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 177
12.3.7.3 Brazil Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 178
12.3.7.4 Brazil Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 179
12.3.7.5 Argentina Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 180
12.3.7.6 Argentina Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 180
12.3.7.7 Argentina Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 181
12.3.7.8 Argentina Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 182
12.3.7.9 ROSA Nuclear Medicine Market Volume Overview, By Product Type, 2015 – 2028 (TBq) 183
12.3.7.10 ROSA Nuclear Medicine Market Revenue Overview, By Product Type, 2015 – 2028 (USD Million) 183
12.3.7.11 ROSA Nuclear Medicine Market Volume Overview, By Application, 2015 – 2028 (TBq) 184
12.3.7.12 ROSA Nuclear Medicine Market Revenue Overview, By Application, 2015 – 2028 (USD Million) 185
Chapter 13 Competitive Landscape 186
13.1 Competitive Environment, 2021 186
13.2 Strategic Framework 187
13.2.1 Recent Initiatives 187
13.3 Top Players Positing 188
Chapter 14 Key Vendor Analysis 189
14.1 Cardinal Health 189
14.1.1 Company Basic information 189
14.1.2 Company Profile: 189
14.1.3 Financial Overview (USD Million) 190
14.1.4 Product Benchmarking 190
14.1.5 Recent Developments 190
14.1.6 SWOT Analysis 191
14.2 Curium 192
14.2.1 Company Basic information 192
14.2.2 Company Profile: 192
14.2.3 Financial Overview 193
14.2.4 Product Benchmarking 193
14.2.5 Recent Developments 194
14.2.6 SWOT Analysis 194
14.3 Lantheus 195
14.3.1 Company Basic information 195
14.3.2 Company Profile: 195
14.3.3 Financial Overview (USD Million) 196
14.3.4 Product Benchmarking 196
14.3.5 Recent developments 196
14.3.6 SWOT Analysis 197
14.4 Bracco 198
14.4.1 Company Basic information 198
14.4.2 Company Profile: 198
14.4.3 Financial Overview 199
14.4.4 Product Benchmarking 199
14.4.5 Recent developments 199
14.4.6 SWOT Analysis 200
14.5 Nordion Inc 201
14.5.1 Company Basic information 201
14.5.2 Company Profile: 201
14.5.3 Financial Overview 201
14.5.4 Product Benchmarking 202
14.5.5 Recent Developments 202
14.5.6 SWOT Analysis 202
14.6 GE Healthcare 203
14.6.1 Company Basic information 203
14.6.2 Company Profile: 203
14.6.3 Financial Overview (USD Billion) 204
14.6.4 Product Benchmarking 204
14.6.5 Recent Developments 204
14.6.6 SWOT Analysis 204
Chapter 15 Manufacturing Nuclear Medicine Cost Analysis 206
15.1 Manufacturing Nuclear Medicine Key Raw Materials Analysis 206
15.1.1 Key Raw Materials 206
15.1.1.1 Mo- 98 206
15.1.1.2 Thallium-81 206
15.1.1.3 Lutetium-176 206
15.1.2 Price Trend of Key Raw Materials - Electromagnetically separated (EM) Molybdenum-98
The Leading Key Players in Nuclear Medicine Market 1
